Milestone Pharmaceuticals (MIST) Interest Expenses (2018 - 2026)

Milestone Pharmaceuticals' Interest Expenses history runs 9 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• Quarterly Interest Expenses fell 21.67% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 21.67% YoY) and the FY2025 annual result came in at $3.8 million, down 95.7% from the prior year.
• Interest Expenses was $1.3 million for Q1 2026 at Milestone Pharmaceuticals, up from $985000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $65.9 million in Q4 2022 and bottomed at $857000.0 in Q4 2023.
• A 5-year average of $6.2 million and a median of $1.7 million in 2024 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses advanced 23.14% — and 2023, when it plunged 98.7%.
• Milestone Pharmaceuticals' Interest Expenses stood at $65.9 million in 2022, then plunged by 98.7% to $857000.0 in 2023, then increased by 7.23% to $919000.0 in 2024, then increased by 7.18% to $985000.0 in 2025, then advanced by 28.83% to $1.3 million in 2026.
• Business Quant data shows MIST's Interest Expenses at $1.3 million in Q1 2026, $985000.0 in Q4 2025, and $1.5 million in Q3 2025.